Oral Answers to Questions Debate
Full Debate: Read Full DebateEmily Darlington
Main Page: Emily Darlington (Labour - Milton Keynes Central)Department Debates - View all Emily Darlington's debates with the Department for Science, Innovation & Technology
(1 day, 17 hours ago)
Commons ChamberOne really important part of the industrial strategy we published on Monday and the sector plans within it is that we identified a problem many people in the UK face, which is that they have a really good idea but cannot take it to market because they do not have access to finance, in particular to capital, unless they are in London—and sometimes unless they are a man. We want to change all that, which is why we have said categorically that we are giving the British Business Bank much more significant power to be able to invest in these sectors. That will mean we are a powerhouse in precisely the way the hon. Member wants.
From the development of vaccines to the discovery of the structure of DNA, British medical innovation has played a fundamental role in changing the lives of people globally and extending the UK’s global influence. Our industrial strategy and forthcoming life sciences sector plan will put the UK at the very centre of global efforts.
As the Minister will know, Gavi and the Global Fund not only provide a global vaccine programmes and programmes on saving lives from malaria and HIV, but provide us with biosecurity and jobs in the UK, not least over 500 research and development jobs and funding for the institute of tropical medicine. What assessment has he made of whether the UK is to reduce our efforts in that regard?
Gavi, the Vaccine Alliance is absolutely essential, not only for other countries in the world, where we have managed to save many lives by introducing vaccines, but for UK innovation. We are fully committed to Gavi. We will be producing our life sciences sector plan soon, and we want to celebrate the sector, which represents 6,800 business and £100 billion of turnover every year.